Advanced Oral Oncology Therapy Supply
Tegafur + Gimeracil + Oteracil Capsules are a clinically recognized oral chemotherapy combination used in oncology treatment protocols for gastrointestinal and solid tumor management under specialist supervision.
This formulation is globally known in oncology markets as an advanced fluoropyrimidine-based therapy (S-1 capsule formulation) designed to improve drug stability, enhance efficacy, and reduce gastrointestinal degradation.
We are a specialized oncology medicine exporter from India, supplying to regulated and semi-regulated markets worldwide with consistent quality and documentation support.
🌍 Global Export Markets
We actively supply oncology distributors and pharmaceutical importers in:
- 🇺🇸 United States (USA Oncology Supply Chain)
- 🇩🇪 Germany (EU Regulated Pharmaceutical Market)
- 🇬🇧 United Kingdom (UK Oncology Distributors)
- 🇦🇪 United Arab Emirates (Middle East Pharma Importers)
- 🇧🇷 Brazil (Latin America Oncology Procurement)
- 🇿🇦 South Africa (African Healthcare Oncology Supply)
💊 Product Specifications
Product Name: Tegafur + Gimeracil + Oteracil Capsules
Available Strengths:
- 15mg / 4.35mg / 11.8mg formulation
- 20mg / 5.8mg / 15.8mg formulation
Dosage Form: Oral Hard Gelatin Capsules
Category: Oncology / Anti-Cancer Medicine
Therapeutic Segment: Oral Chemotherapy Agents
Prescription Type: Hospital & Oncology Specialist Use Only
Packaging: Export-grade blister / HDPE bottle (customizable)
⚙️ Mechanism of Action (Simplified Overview)
This oncology combination works through a synergistic mechanism:
- Tegafur: Prodrug converted into active anti-cancer agent
- Gimeracil: Enhances therapeutic concentration by slowing metabolism
- Oteracil: Reduces gastrointestinal toxicity and improves tolerability
This makes it a widely used oral fluoropyrimidine chemotherapy option in oncology practice.
🎯 Key Benefits for Global Buyers
✔ High-demand oncology molecule in global cancer treatment supply chains
✔ Oral chemotherapy formulation (hospital-friendly administration)
✔ Stable export packaging for international logistics
✔ Suitable for government tenders & institutional procurement
✔ WHO-GMP compliant manufacturing sources (on request basis)
✔ Consistent bulk supply for pharmaceutical distributors
🏥 Therapeutic Applications
Tegafur + Gimeracil + Oteracil Capsules are commonly used in:
- Gastric cancer treatment protocols
- Gastrointestinal oncology management
- Metastatic solid tumor therapies
- Combination chemotherapy regimens under oncology supervision
- Hospital-based cancer treatment programs
📦 Supply & Export Capability
We support global pharmaceutical buyers with:
- Bulk oncology medicine export supply
- Private label & contract manufacturing options
- Regulatory documentation support (COA, MSDS, GMP)
- Export packaging customization
- Fast international shipping coordination
- Distributor onboarding assistance
❓ Frequently Asked Questions (SEO Boost Section)
Q1. Is this medicine used for chemotherapy?
Yes, it is an oral chemotherapy agent used in oncology treatment protocols under medical supervision.
Q2. Do you supply for international markets?
Yes, we supply to USA, EU, UK, UAE, Brazil, and African markets through compliant export channels.
Q3. Can bulk orders be arranged?
Yes, bulk oncology medicine supply is available for distributors, hospitals, and importers.
Q4. Is documentation provided for import?
Yes, regulatory documents like COA, GMP, and export invoices are available as per requirement.
🚀 Business Enquiry & Global Orders
For oncology distributors, hospital procurement teams, and pharmaceutical importers:
📱 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com